ELVN Operating Expenses

Enliven Therapeutics Inc · Operating Expenses

ELVN logo

ELVN Operating Expenses

Latest reported$124.37M
ELVN TTM Operating Expenses ($24.12M → $124.37M)
High-resolution chart · PNG

ELVN operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Enliven Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
124,367,000
115,742,000
119,612,000
112,269,000
114,241,000
110,260,000
104,554,000
100,387,000
97,567,000
93,098,000
83,529,000
70,963,000
57,649,000
46,531,000
38,791,000
37,023,000
39,724,000
43,852,000
45,429,000
48,584,000
47,443,000
44,601,000
41,698,000
37,631,000
32,019,000
27,274,000
24,116,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.